Evidence map›Paper›PMID 21346588›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2011

Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana.

Nina H Lin, Laura M Smeaton, Françoise Giguel, Vladimir Novitsky, Sikhulile Moyo, Rebecca M Mitchell, Joseph Makhema, Myron Essex, Shahin Lockman, Daniel R Kuritzkes

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. HIV-1CViruses · 2020
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Nina H LinDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Laura M Smeaton
Françoise Giguel
Vladimir Novitsky
Sikhulile Moyo
Rebecca M Mitchell
Joseph Makhema
Myron Essex
Shahin Lockman
Daniel R Kuritzkes
Botswana Harvard AIDS Institute Partnership · BWHarvard University · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
PREVENTION OF MILK-BORNE TRANSMISSION OF HIV IN BOTSWANAR01HD037793 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ESSEX, MYRON E · 2000 to 2004
$6.9M
Maternal and Infant Health and HAART Outcomes in the Mashi PMTCT Study, BotswanaR01HD044391 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LOCKMAN, SHAHIN · 2003 to 2010
$1.9M
HIV-1 THERAPEUTICS AND DRUG RESISTANCEK24RR016482 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KURITZKES, DANIEL R. · 2001 to 2010
$1.0M
Analysis of properties of HIV-1 subtype C envelope glycoproteinK08AI081545 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LIN, NINA H. · 2011 to 2015
$675k
FIC NIH HHS R24 TW007988FIC NIH HHS R24TW007988NCRR NIH HHS K24 RR016482NIAID NIH HHS 2P30AI060354-06NIAID NIH HHS K08 AI081545NIAID NIH HHS P30 AI060354NIAID NIH HHS T32 AI007387NIAID NIH HHS U01 AI068636NICHD NIH HHS R01 HD037793NICHD NIH HHS R01 HD044391
6 · The paper itself

Abstract

HIV-1 coreceptor use was determined using a phenotypic assay in plasma samples from treatment-naive women infected with subtype C virus who had CD4 cell counts below 200 cells/mm3. Of 148 women, 14.9% were infected with dual/mixed virus; the remainder had R5 virus. A greater proportion of women in the lowest CD4 cell count stratum had dual/mixed virus (P = 0.026); change in coreceptor use after antiretroviral therapy exposure was uncommon. CXCR4-using HIV-1 was less common in subtype C-infected women than reported in subtype B cohorts but was most prevalent in women with the lowest CD4 cell counts.

Indexed as

AdultBotswanaCD4 Lymphocyte CountCohort StudiesFemaleHIV-1HIV InfectionsHumansPrevalenceReceptors, CXCR4RNA, ViralCXCR4 protein, humanReceptors, CXCR4RNA, Viral

Identifiers

PMID21346588
PMCPMC3353541
OpenAlexW2030872787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.